Taiwanese camellia oil exceeds cancer-causing chemical limits; probe launched
Translated from Chinese, summarized and contextualized by DistantNews.
At a glance
- Taiwan's Food and Drug Administration (FDA) reported that "Lian Jing Camellia Oil" products exceeded the permissible levels of benzopyrene.
- The contamination may be related to the manufacturing process, according to the FDA.
- Health authorities are investigating the company, Lian Jing Green Technology, after it self-reported the issue.
Taiwan's Food and Drug Administration (FDA) has announced that certain "Lian Jing Camellia Oil" products have been found to contain levels of benzopyrene exceeding regulatory limits. Benzopyrene is a chemical compound that can be harmful to human health, and its presence in food products is strictly controlled.
The FDA indicated that the contamination might stem from the manufacturing process employed by the company, Lian Jing Green Technology. The agency, along with the New Taipei City Government's health department, visited the company's premises on July 22 to conduct an on-site inspection and collect samples.
This development follows a previous case involving contaminated camellia oil from a company named Zhonglian Oil, suggesting ongoing concerns about quality control within the industry. The self-reporting by Lian Jing Green Technology has initiated an official investigation into the matter by Taiwanese health authorities.
Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.